EyePoint Pharmaceuticals, Inc.·4

Oct 17, 4:49 PM ET

Duty Stuart 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Oct 17, 2023

Insider Transaction Report

Form 4
Period: 2023-10-16
Duty Stuart
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-16+60,00060,000 total
    Exercise: $8.23Exp: 2033-10-15Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in three ratable annual installments beginning on October 16, 2024.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT